ElectroDose: Wearable Sensor for Quantitation of Pulsed Electromagnetic Therapy
Project number:
23086
Sponsor:
Regenesis Biomedical, Inc
Academic year:
2022-2023
Project Goal: Design and build a wearable sensor system able to determine patient receipt and dose of Pulsed Electromagnetic (PEMF) Therapy delivered by Regenesis therapeutic technologies. The wearable device/system to be built by the team will serve as a "diagnostic/monitoring compliment" to Regenesis energy delivery systems. The wearable system to be built will specifically determine: 1. Receipt of therapy (yes/no); 2. Time of therapy session; 3. Duration of therapy; 4. Intensity of PEMF signal. 5. Nature of signal - i.e., Whether received from a single-pad or dual-pad device. System will also be able to: 7. store data 8. Telemeter/download data. The team will utilize work done in 2021-2022 to improve and build upon a fundamental design already developed - making the system smaller, more robust and more user-friendly. The team will also formulate a plan to manufacture (i.e., mass-produce) the wearable PEMF sensor considering a multi-dimensional set of constraints; including supply chain, design for manufacturing, testing, and required personnel.
Project Background/Scope: Pulsed electromagnetic field (PEMF) has been demonstrated to be a therapeutic modality capable of modulating a range of biologic and pathophysiologic body responses. To date the delivery of PEMF has been shown to enhance healing of chronic tissue ulcers. PEMF has also been demonstrated to accelerated wound closure. Of note PEMF has been able to modulate neuroinflammatory responses underlying chronic pain. As such, PEMF has been demonstrated to be, and has emerged as, a safe and effective, non-drug based therapeutic means of reducing pain. Regenesis Biomedical manufactures an effective FDA cleared therapeutic system able to delivery PEMF.
Why build a sensor? Much like dosing of a medication, non-pharmacologic therapies need to be monitored in terms of actual delivery and receipt by the subject of the applied therapy. This is the goal of the current project. Here the project team will build an effective system able to determine that a patient actually has undertaken and received PEMF therapy. The system will quantitate the dose = intensity x time. The system will be able to differentiate whether the patient has used a single-pad or dual-pad delivery system, as well as log and transfer data for analysis.
Requirements: The system to be built will specifically determine: 1. Receipt of PEMF therapy (yes/no); 2. Time of therapy session; 3. Duration of therapy; 4. Intensity of PEMF signal. 5. Nature of signal – i.e. Whether received from a single-pad or dual-pad device. System will also: 7. store data 8. Telemeter/download data. The team will utilize work done in 2021-2022 to improve and build upon a fundamental design already developed - making the system smaller, more robust and more user-friendly. The team will improve the prior benchtop prototype to advance it to be ready for manufacturing, demonstrating the integration of electrical design, embedded software, mechanical design, and smartphone application. The team will also formulate a plan to manufacture (i.e., mass-produce) the wearable PEMF sensor considering a multi-dimensional set of constraints; including supply chain, design for manufacturing, testing, and required personnel.
Project Background/Scope: Pulsed electromagnetic field (PEMF) has been demonstrated to be a therapeutic modality capable of modulating a range of biologic and pathophysiologic body responses. To date the delivery of PEMF has been shown to enhance healing of chronic tissue ulcers. PEMF has also been demonstrated to accelerated wound closure. Of note PEMF has been able to modulate neuroinflammatory responses underlying chronic pain. As such, PEMF has been demonstrated to be, and has emerged as, a safe and effective, non-drug based therapeutic means of reducing pain. Regenesis Biomedical manufactures an effective FDA cleared therapeutic system able to delivery PEMF.
Why build a sensor? Much like dosing of a medication, non-pharmacologic therapies need to be monitored in terms of actual delivery and receipt by the subject of the applied therapy. This is the goal of the current project. Here the project team will build an effective system able to determine that a patient actually has undertaken and received PEMF therapy. The system will quantitate the dose = intensity x time. The system will be able to differentiate whether the patient has used a single-pad or dual-pad delivery system, as well as log and transfer data for analysis.
Requirements: The system to be built will specifically determine: 1. Receipt of PEMF therapy (yes/no); 2. Time of therapy session; 3. Duration of therapy; 4. Intensity of PEMF signal. 5. Nature of signal – i.e. Whether received from a single-pad or dual-pad device. System will also: 7. store data 8. Telemeter/download data. The team will utilize work done in 2021-2022 to improve and build upon a fundamental design already developed - making the system smaller, more robust and more user-friendly. The team will improve the prior benchtop prototype to advance it to be ready for manufacturing, demonstrating the integration of electrical design, embedded software, mechanical design, and smartphone application. The team will also formulate a plan to manufacture (i.e., mass-produce) the wearable PEMF sensor considering a multi-dimensional set of constraints; including supply chain, design for manufacturing, testing, and required personnel.
Get started and sponsor a project now!
UA engineering students are ready to take your project from concept to reality.